Researchers have developed a new blood test that detects early stage ovarian cancer and may determine whether a pelvic mass is benign or cancerous with 91 per cent accuracy, a rate better than existing tests.
News Today | First with the news
News Today | First with the news
Researchers have developed a new blood test that detects early stage ovarian cancer and may determine whether a pelvic mass is benign or cancerous with 91 per cent accuracy, a rate better than existing tests.